Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics

NCT01811160 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Second Generation Antipsychotic Induced Metabolic Adverse Effects

Interventions

DRUG: Melatonin
DRUG: Placebo

Sponsor

Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente